Media Database
>
Christine Parry

Christine Parry

Lead Writer / Freelance Science Writer at The Pharmaceutical Journal

Contact this person
Email address
c*****@*******.comGet email address
Influence score
41
Phone
(XXX) XXX-XXXX Get mobile number
Location
United Kingdom
Languages
  • English
Covering topics
  • Science

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

pharmaceutical-journal.com

Beyond antibiotics: harnessing bacteria’s natural predators

With antibiotic resistance set to cost 10 million lives per year by 2050, there is a renaissance of interest in the potential of bacteriophages to be the next generation of bacteria killers.
pharmaceutical-journal.com

Taking the P: why the founder of P -values would be turning in his ...

How P-values are used today has gradually morphed further and further from their intended use and scientists are now questioning the prominence they are given when interpreting clinical trial data.
pharmaceutical-journal.com

Fatal mistakes: why do ten-fold medication errors in children keep ...

“Ten-fold medication errors in children are a problem everyone fears,” says consultant paediatric nephrologist Yincent Tse. “Everyone’s seen it happen before, but we’ve never really measured it or taken a wide view of it. We’ve never really had good data,” adds Tse, who is lead for patient safety and quality improvement on the Royal College […]
pharmaceutical-journal.com

Why it is too soon to celebrate the Alzheimer’s ‘wonder drug’

It should have been a cause for celebration: the first-in-class, disease-modifying drug that reaches beyond alternative symptomatic treatments to target an underlying cause of Alzheimer’s disease (AD) directly. However, the approval of aducanumab (Aduhelm; Biogen) in June 2021 by the US Food and Drug Administration (FDA) has instead resulted in resignations, division and claims of […]
pharmaceutical-journal.com

Opening the black box: the researchers trying to find treatments fo...

When patients began reporting lingering symptoms following COVID-19 infection, just a few months into the 2020 pandemic, initially they were ignored. “We owe a debt to patients here,” stresses Amitava Banerjee, professor of clinical data science at University College London. “Remember in May 2020 — it was patients who defined this, not doctors, not researchers, […]
pharmaceutical-journal.com

Chronic fatigue: it is time to take its treatment more seriously

“One in four consultations in primary care involve fatigue — it’s the most common reason why people go to see their GP,” says Julia Newton, a consultant physician with an interest in fatigue at Newcastle upon Tyne Hospitals NHS Foundation Trust. At least 250,000 people in the UK live with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), […]
pharmaceutical-journal.com

Should we be genetic testing before prescribing analgesics?

Not only is the biology of pain incredibly complex, but pain intensity can be altered by social and psychological factors, such as anxiety and stress levels, living conditions, or even cultural attitudes towards pain. The unique combination of these factors gives rise to inter-individual differences in pain perception and variable analgesic response​[1,2]​. “We tend to […]
pharmaceutical-journal.com

Prepare to say ‘Hi!’ to your virtual AI assistant

Imagine if next time you consult with a patient, you have an expert in the relevant field sat next to you, scouring the latest scientific literature, combing through millions of case studies in seconds, and applying this knowledge in an instant to help you provide the best possible care. Sounds too good to be true? […]
pharmaceutical-journal.com

AI chatbots in pharmacy: a brave new world or looming threat?

The rash of artificial intelligence (AI) chatbots breaking out across our screens has got everyone poking and prodding at them and wondering — is this something I need to see a doctor about? The unrelenting pace of AI advancement has rapidly shifted to place healthcare at the centre of the developers’ crosshairs. AI chatbots are […]